Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SODG93A mice co-expressing the Copper-Chaperone-for-SOD

Jared R. Williams, Emiliano Trias, Pamela R. Beilby, Nathan I. Lopez, Edwin M. Labut, C. Samuel Bradford, Blaine R. Roberts, Erin J. McAllum, Peter J. Crouch, Timothy W. Rhoads, Cliff Pereira, Marjatta Son, Jeffrey L. Elliott, Maria Clara Franco, Alvaro G. Estévez, Luis Barbeito, Joseph S. Beckman

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Over-expression of mutant copper, zinc superoxide dismutase (SOD) in mice induces ALS and has become the most widely used model of neurodegeneration. However, no pharmaceutical agent in 20 years has extended lifespan by more than a few weeks. The Copper-Chaperone-for-SOD (CCS) protein completes the maturation of SOD by inserting copper, but paradoxically human CCS causes mice co-expressing mutant SOD to die within two weeks of birth. Hypothesizing that co-expression of CCS created copper deficiency in spinal cord, we treated these pups with the PET-imaging agent CuATSM, which is known to deliver copper into the CNS within minutes. CuATSM prevented the early mortality of CCSxSOD mice, while markedly increasing Cu, Zn SOD protein in their ventral spinal cord. Remarkably, continued treatment with CuATSM extended the survival of these mice by an average of 18 months. When CuATSM treatment was stopped, these mice developed ALS-related symptoms and died within 3 months. Restoring CuATSM treatment could rescue these mice after they became symptomatic, providing a means to start and stop disease progression. All ALS patients also express human CCS, raising the hope that familial SOD ALS patients could respond to CuATSM treatment similarly to the CCSxSOD mice.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalNeurobiology of Disease
Volume89
DOIs
StatePublished - May 1 2016

Fingerprint

Motor Neuron Disease
Superoxide Dismutase
Copper
Spinal Cord
Therapeutics
Disease Progression
Zinc
Proteins
Parturition
Mortality

Keywords

  • Amyotrophic lateral sclerosis
  • CCS
  • Lou Gehrig
  • SOD1
  • Superoxide dismutase

ASJC Scopus subject areas

  • Neurology

Cite this

Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SODG93A mice co-expressing the Copper-Chaperone-for-SOD. / Williams, Jared R.; Trias, Emiliano; Beilby, Pamela R.; Lopez, Nathan I.; Labut, Edwin M.; Bradford, C. Samuel; Roberts, Blaine R.; McAllum, Erin J.; Crouch, Peter J.; Rhoads, Timothy W.; Pereira, Cliff; Son, Marjatta; Elliott, Jeffrey L.; Franco, Maria Clara; Estévez, Alvaro G.; Barbeito, Luis; Beckman, Joseph S.

In: Neurobiology of Disease, Vol. 89, 01.05.2016, p. 1-9.

Research output: Contribution to journalArticle

Williams, JR, Trias, E, Beilby, PR, Lopez, NI, Labut, EM, Bradford, CS, Roberts, BR, McAllum, EJ, Crouch, PJ, Rhoads, TW, Pereira, C, Son, M, Elliott, JL, Franco, MC, Estévez, AG, Barbeito, L & Beckman, JS 2016, 'Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SODG93A mice co-expressing the Copper-Chaperone-for-SOD', Neurobiology of Disease, vol. 89, pp. 1-9. https://doi.org/10.1016/j.nbd.2016.01.020
Williams, Jared R. ; Trias, Emiliano ; Beilby, Pamela R. ; Lopez, Nathan I. ; Labut, Edwin M. ; Bradford, C. Samuel ; Roberts, Blaine R. ; McAllum, Erin J. ; Crouch, Peter J. ; Rhoads, Timothy W. ; Pereira, Cliff ; Son, Marjatta ; Elliott, Jeffrey L. ; Franco, Maria Clara ; Estévez, Alvaro G. ; Barbeito, Luis ; Beckman, Joseph S. / Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SODG93A mice co-expressing the Copper-Chaperone-for-SOD. In: Neurobiology of Disease. 2016 ; Vol. 89. pp. 1-9.
@article{4440564eec9b4e30be136097d286456e,
title = "Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SODG93A mice co-expressing the Copper-Chaperone-for-SOD",
abstract = "Over-expression of mutant copper, zinc superoxide dismutase (SOD) in mice induces ALS and has become the most widely used model of neurodegeneration. However, no pharmaceutical agent in 20 years has extended lifespan by more than a few weeks. The Copper-Chaperone-for-SOD (CCS) protein completes the maturation of SOD by inserting copper, but paradoxically human CCS causes mice co-expressing mutant SOD to die within two weeks of birth. Hypothesizing that co-expression of CCS created copper deficiency in spinal cord, we treated these pups with the PET-imaging agent CuATSM, which is known to deliver copper into the CNS within minutes. CuATSM prevented the early mortality of CCSxSOD mice, while markedly increasing Cu, Zn SOD protein in their ventral spinal cord. Remarkably, continued treatment with CuATSM extended the survival of these mice by an average of 18 months. When CuATSM treatment was stopped, these mice developed ALS-related symptoms and died within 3 months. Restoring CuATSM treatment could rescue these mice after they became symptomatic, providing a means to start and stop disease progression. All ALS patients also express human CCS, raising the hope that familial SOD ALS patients could respond to CuATSM treatment similarly to the CCSxSOD mice.",
keywords = "Amyotrophic lateral sclerosis, CCS, Lou Gehrig, SOD1, Superoxide dismutase",
author = "Williams, {Jared R.} and Emiliano Trias and Beilby, {Pamela R.} and Lopez, {Nathan I.} and Labut, {Edwin M.} and Bradford, {C. Samuel} and Roberts, {Blaine R.} and McAllum, {Erin J.} and Crouch, {Peter J.} and Rhoads, {Timothy W.} and Cliff Pereira and Marjatta Son and Elliott, {Jeffrey L.} and Franco, {Maria Clara} and Est{\'e}vez, {Alvaro G.} and Luis Barbeito and Beckman, {Joseph S.}",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.nbd.2016.01.020",
language = "English (US)",
volume = "89",
pages = "1--9",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SODG93A mice co-expressing the Copper-Chaperone-for-SOD

AU - Williams, Jared R.

AU - Trias, Emiliano

AU - Beilby, Pamela R.

AU - Lopez, Nathan I.

AU - Labut, Edwin M.

AU - Bradford, C. Samuel

AU - Roberts, Blaine R.

AU - McAllum, Erin J.

AU - Crouch, Peter J.

AU - Rhoads, Timothy W.

AU - Pereira, Cliff

AU - Son, Marjatta

AU - Elliott, Jeffrey L.

AU - Franco, Maria Clara

AU - Estévez, Alvaro G.

AU - Barbeito, Luis

AU - Beckman, Joseph S.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Over-expression of mutant copper, zinc superoxide dismutase (SOD) in mice induces ALS and has become the most widely used model of neurodegeneration. However, no pharmaceutical agent in 20 years has extended lifespan by more than a few weeks. The Copper-Chaperone-for-SOD (CCS) protein completes the maturation of SOD by inserting copper, but paradoxically human CCS causes mice co-expressing mutant SOD to die within two weeks of birth. Hypothesizing that co-expression of CCS created copper deficiency in spinal cord, we treated these pups with the PET-imaging agent CuATSM, which is known to deliver copper into the CNS within minutes. CuATSM prevented the early mortality of CCSxSOD mice, while markedly increasing Cu, Zn SOD protein in their ventral spinal cord. Remarkably, continued treatment with CuATSM extended the survival of these mice by an average of 18 months. When CuATSM treatment was stopped, these mice developed ALS-related symptoms and died within 3 months. Restoring CuATSM treatment could rescue these mice after they became symptomatic, providing a means to start and stop disease progression. All ALS patients also express human CCS, raising the hope that familial SOD ALS patients could respond to CuATSM treatment similarly to the CCSxSOD mice.

AB - Over-expression of mutant copper, zinc superoxide dismutase (SOD) in mice induces ALS and has become the most widely used model of neurodegeneration. However, no pharmaceutical agent in 20 years has extended lifespan by more than a few weeks. The Copper-Chaperone-for-SOD (CCS) protein completes the maturation of SOD by inserting copper, but paradoxically human CCS causes mice co-expressing mutant SOD to die within two weeks of birth. Hypothesizing that co-expression of CCS created copper deficiency in spinal cord, we treated these pups with the PET-imaging agent CuATSM, which is known to deliver copper into the CNS within minutes. CuATSM prevented the early mortality of CCSxSOD mice, while markedly increasing Cu, Zn SOD protein in their ventral spinal cord. Remarkably, continued treatment with CuATSM extended the survival of these mice by an average of 18 months. When CuATSM treatment was stopped, these mice developed ALS-related symptoms and died within 3 months. Restoring CuATSM treatment could rescue these mice after they became symptomatic, providing a means to start and stop disease progression. All ALS patients also express human CCS, raising the hope that familial SOD ALS patients could respond to CuATSM treatment similarly to the CCSxSOD mice.

KW - Amyotrophic lateral sclerosis

KW - CCS

KW - Lou Gehrig

KW - SOD1

KW - Superoxide dismutase

UR - http://www.scopus.com/inward/record.url?scp=84959280730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959280730&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2016.01.020

DO - 10.1016/j.nbd.2016.01.020

M3 - Article

C2 - 26826269

AN - SCOPUS:84959280730

VL - 89

SP - 1

EP - 9

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

ER -